No significant differences between the temporality of peritoneal metastasis (metachronous vs. synchronous) were found in relation to sex (p = 0.1), KRAS mutation (p = 0.212), metastasis type to extraperitoneal metastatic organs (p = 0.092) or HIPEC administration (p = 0.084). Here, KRAS is linked to metastasis.